LRMR insider filings

Larimar Therapeutics, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-18. Screen LRMR transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 11 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
Hamilton Thomas Edward — Director11 leg · 70,000 sh · $187,082——
Celano Michael — Chief Financial Officer11 leg · 18,460 sh · $49,992——
BEN-MAIMON CAROLE — President and CEO, Director11 leg · 18,050 sh · $49,953——
Harlow John B. Jr. — President and COO31 leg · 17,800 sh · $49,918—2
THOMAS FRANK E — Director11 leg · 8,000 sh · $21,800——
Shankar Gopi — Chief Development Officer11 leg · 5,000 sh · $13,549——
SHERMAN JEFFREY W — Director11 leg · 3,289 sh · $10,058——
Clayton Russell — Chief Medical Officer11 leg · 3,322 sh · $9,999——
Truitt Joseph — Director11 leg · 3,500 sh · $9,792——

Recent insider filings — Larimar Therapeutics, Inc.

FiledFormInsiderReported transactionsSource
2026-11-184Clayton Russell — Chief Medical OfficerPurchase (P): 3,322 @ $3.01EDGAR
2026-11-164SHERMAN JEFFREY W — DirectorPurchase (P): 3,289.47 @ $3.06EDGAR
2026-11-124Hamilton Thomas Edward — DirectorPurchase (P): 70,000 @ $2.67EDGAR
2026-11-124BEN-MAIMON CAROLE — President and CEO, DirectorPurchase (P): 18,050 @ $2.77EDGAR
2026-11-124Truitt Joseph — DirectorPurchase (P): 3,500 @ $2.80EDGAR
2026-11-124THOMAS FRANK E — DirectorPurchase (P): 8,000 @ $2.73EDGAR
2026-11-124Harlow John B. Jr. — President and COOPurchase (P): 17,800 @ $2.80EDGAR
2026-11-124Celano Michael — Chief Financial OfficerPurchase (P): 18,460 @ $2.71EDGAR
2026-11-124Shankar Gopi — Chief Development OfficerPurchase (P): 5,000 @ $2.71EDGAR
2026-10-013Harlow John B. Jr. — President and COOHoldings only — no transactions reportedEDGAR
2026-10-014Harlow John B. Jr. — President and COOGrant/award (A): 50,000 @ $0 · Grant/award (A): 800,000 (derivative) @ $0EDGAR
2026-07-084Hamilton Thomas Edward — DirectorPurchase (P): 50,000 @ $3.34EDGAR
2026-05-204Truitt Joseph — DirectorGrant/award (A): 55,150 (derivative) @ $0EDGAR
2026-05-204Hamilton Thomas Edward — DirectorGrant/award (A): 55,150 (derivative) @ $0EDGAR
2026-05-204THOMAS FRANK E — DirectorGrant/award (A): 55,150 (derivative) @ $0EDGAR
2026-05-204SHERMAN JEFFREY W — DirectorGrant/award (A): 55,150 (derivative) @ $0EDGAR
2026-05-204LEFF JONATHAN S — DirectorGrant/award (A): 55,150 (derivative) @ $0EDGAR
2026-05-204Flynn James E — Director, 10% owner
DEERFIELD MANAGEMENT COMPANY, L.P. — Director, 10% owner
Grant/award (A): 55,150 (derivative) @ $0EDGAR
2026-03-024Hamilton Thomas Edward — DirectorPurchase (P): 100,000 @ $5EDGAR
2026-03-024THOMAS FRANK E — DirectorPurchase (P): 5,000 @ $5EDGAR
2026-03-024SHERMAN JEFFREY W — DirectorPurchase (P): 5,000 @ $5EDGAR
2026-03-024Flynn James E — Director, 10% owner
DEERFIELD MANAGEMENT COMPANY, L.P. — Director, 10% owner
Deerfield Mgmt III, L.P. — Director, 10% owner
Deerfield Mgmt HIF, L.P. — Director, 10% owner
Deerfield Mgmt IV, L.P. — Director, 10% owner
Deerfield Mgmt L.P. — Director, 10% owner
Deerfield Private Design Fund III, L.P. — Director, 10% owner
Deerfield Healthcare Innovations Fund, L.P. — Director, 10% owner
Deerfield Private Design Fund IV, L.P. — Director, 10% owner
DEERFIELD PARTNERS, L.P. — Director, 10% owner
Purchase (P): 1,084,010 @ $5 · Purchase (P): 1,084,012 @ $5 · Purchase (P): 831,978 @ $5 · Purchase (P): 2,000,000 @ $5EDGAR
2026-01-274Shankar Gopi — Chief Development OfficerGrant/award (A): 25,637 @ $0 · Grant/award (A): 153,822 (derivative) @ $0EDGAR
2026-01-274Clayton Russell — Chief Medical OfficerGrant/award (A): 25,637 @ $0 · Grant/award (A): 153,822 (derivative) @ $0EDGAR
2026-01-274BEN-MAIMON CAROLE — President and CEO, DirectorGrant/award (A): 100,100 @ $0 · Grant/award (A): 600,600 (derivative) @ $0EDGAR
2026-01-274Celano Michael — Chief Financial OfficerGrant/award (A): 37,604 @ $0 · Grant/award (A): 225,622 (derivative) @ $0EDGAR
2025-08-044Flynn James E — Director, 10% owner
DEERFIELD MANAGEMENT COMPANY, L.P. — Director, 10% owner
Deerfield Mgmt III, L.P. — Director, 10% owner
Deerfield Mgmt HIF, L.P. — Director, 10% owner
Deerfield Mgmt IV, L.P. — Director, 10% owner
Deerfield Mgmt L.P. — Director, 10% owner
Deerfield Private Design Fund III, L.P. — Director, 10% owner
Deerfield Healthcare Innovations Fund, L.P. — Director, 10% owner
Deerfield Private Design Fund IV, L.P. — Director, 10% owner
DEERFIELD PARTNERS, L.P. — Director, 10% owner
Purchase (P): 3,387,529 @ $3.20 · Purchase (P): 3,387,539 @ $3.20 · Purchase (P): 2,599,932 @ $3.20EDGAR
2025-05-154Flynn James E — Director, 10% owner
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) — Director, 10% owner
Grant/award (A): 19,000 (derivative) @ $0EDGAR
2025-05-144Truitt Joseph — DirectorGrant/award (A): 19,000 (derivative) @ $0EDGAR
2025-05-144Hamilton Thomas Edward — DirectorGrant/award (A): 19,000 (derivative) @ $0EDGAR
2025-05-144THOMAS FRANK E — DirectorGrant/award (A): 19,000 (derivative) @ $0EDGAR
2025-05-144SHERMAN JEFFREY W — DirectorGrant/award (A): 19,000 (derivative) @ $0EDGAR
2025-05-144LEFF JONATHAN S — DirectorGrant/award (A): 19,000 (derivative) @ $0EDGAR
2025-01-244Shankar Gopi — Chief Development OfficerGrant/award (A): 23,306 @ $0 · Grant/award (A): 139,838 (derivative) @ $0EDGAR
2025-01-244Clayton Russell — Chief Medical OfficerGrant/award (A): 23,306 @ $0 · Grant/award (A): 139,838 (derivative) @ $0EDGAR
2025-01-244BEN-MAIMON CAROLE — President and CEO, DirectorGrant/award (A): 91,000 @ $0 · Grant/award (A): 546,000 (derivative) @ $0EDGAR
2025-01-244Celano Michael — Chief Financial OfficerGrant/award (A): 34,185 @ $0 · Grant/award (A): 205,111 (derivative) @ $0EDGAR
2024-06-034Flynn James E — Director, 10% owner
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) — Director, 10% owner
Grant/award (A): 19,000 (derivative) @ $0EDGAR
2024-05-314Truitt Joseph — DirectorGrant/award (A): 19,000 (derivative) @ $0EDGAR
2024-05-314Hamilton Thomas Edward — DirectorPurchase (P): 57,208 @ $8.74 · Grant/award (A): 19,000 (derivative) @ $0EDGAR
2024-05-314THOMAS FRANK E — DirectorGrant/award (A): 19,000 (derivative) @ $0EDGAR
2024-05-314SHERMAN JEFFREY W — DirectorGrant/award (A): 19,000 (derivative) @ $0EDGAR
2024-05-314LEFF JONATHAN S — DirectorGrant/award (A): 19,000 (derivative) @ $0EDGAR
2024-02-164Flynn James E — Director, 10% owner
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) — Director, 10% owner
Deerfield Mgmt III, L.P. — Director, 10% owner
Deerfield Mgmt HIF, L.P. — Director, 10% owner
Deerfield Mgmt IV, L.P. — Director, 10% owner
Deerfield Mgmt L.P. — Director, 10% owner
Deerfield Private Design Fund III, L.P. — Director, 10% owner
Deerfield Healthcare Innovations Fund, L.P. — Director, 10% owner
Deerfield Private Design Fund IV, L.P. — Director, 10% owner
DEERFIELD PARTNERS, L.P. — Director, 10% owner
Purchase (P): 1,430,206 @ $8.74 · Purchase (P): 1,430,206 @ $8.74 · Purchase (P): 1,430,205 @ $8.74EDGAR
2024-02-154THOMAS FRANK E — DirectorPurchase (P): 2,000 @ $11EDGAR
2024-01-194Shankar Gopi — Chief Development OfficerGrant/award (A): 22,500 @ $0 · Grant/award (A): 135,000 (derivative) @ $0EDGAR
2024-01-194Celano Michael — Chief Financial OfficerGrant/award (A): 31,250 @ $0 · Grant/award (A): 187,500 (derivative) @ $0EDGAR
2024-01-194Clayton Russell — Chief Medical OfficerGrant/award (A): 22,500 @ $0 · Grant/award (A): 135,000 (derivative) @ $0EDGAR
2024-01-194BEN-MAIMON CAROLE — President and CEO, DirectorGrant/award (A): 66,125 @ $0 · Grant/award (A): 396,750 (derivative) @ $0EDGAR
2023-12-084Shankar Gopi — Chief Development OfficerPurchase (P): 5,000 @ $3.73EDGAR

Recent 8-K events — Larimar Therapeutics, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-168-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-11-098-K2.02 — Results of Operations and Financial Condition
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-298-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-08-048-K2.02 — Results of Operations and Financial Condition
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-298-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-198-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-05-148-K2.02 — Results of Operations and Financial Condition
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-198-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-098-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-02-278-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=LRMR returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs